Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period
Persistence Market Research
Global Opioids Market Has Been Estimated to Account for US$ 34.8 Bn in 2015, Owing to Increased Demand for Pain Medication in Non-cancer Condition and Palliative Care
Persistence Market Research
1
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period
Persistence Market Research (PMR) delivers key insights on the Global Opioids Market in its latest report titled “Global Market Study on Opioids: Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period ”.
Browse Full TOC: http://www.persistencemarketresearch.com/toc/3066
Opioids are naturally occurring opiates and synthetic and semi-synthetic drugs that act on opioid receptors in the brain and can cause dependence due to their euphoric effects. Opioids are majorly categorized into natural and synthetic opioids that are used to treat moderate to severe pain caused due to various physical conditions.
Increasing usage of opioids in non-cancer conditions, unregulated prescription by physicians, lack of regulatory policies to curb the abusive consumption, increasing the prevalence of terminal conditions and favorable reimbursement for palliative care in developed countries are some of the factors promoting the growth of the global opioids market. However, chronic side effects, high prices of opioids in developing countries, over the regulated opioid prescription environment in Asia Pacific and limited availability in Asia Pacific, Africa and some parts of Europe are expected to hinder the growth of the opioids market, globally.
Request
sample
of
this
report:
http://www.persistencemarketresearch.com/samples/3066
This report covers the global opioids market performance in terms of revenue contribution. The report includes key trends, drivers, restraints, and opportunities influencing the growth of the global opioids market. Impact analysis of key growth drivers and restraints, based on the weighted average model are included in this report to better equip clients with crystal clear decision-making insights.
The global opioids market is segmented as follows: •
Opioid market, by Product Type
Persistence Market Research
2
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period
•
Opioid market, by Application
•
Opioid market, by Region
The global opioids market has been estimated to be valued at US$ 34,888.0 Mn in 2015 and is anticipate to garner US$ 42,158.8 Mn revenue by 2021, registering a CAGR of 3.2% during the forecast period. By product, the global opioid market is segmented into morphine, codeine, fentanyl, meperidine and methadone. The morphine and codeine segments collectively accounted for around 62% of the overall market in 2014. By application, the global opioids market is segmented into analgesia, cough suppression and diarrhea suppression. The analgesia segment was valued at US$ 22,776.3 Mn in 2014 and is anticipated to reach US$ 3,448.6 Mn by 2021 at a CAGR of 7.1% over the forecast period. By geography, North America dominated the market with over 65% market share in 2014, followed by Europe. Opioids market in Asia-Pacific is projected to expand at the highest CAGR of 6.7% during the forecast period.
Browse
the
Report
at:
http://www.persistencemarketresearch.com/market-
research/opioids-market.asp
Key players in the global opioids market are Pfizer Inc., Purdue Pharma, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Actavis Plc., Sanofi, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc. and Egalet. These companies are looking for maximum market share with the help of product launch in Abuse Deterrent Formulations (ADF).
Also, major players are focusing on Asia Pacific region especially in
Australia owing to flexible regulation for opium cultivation.
Key features of this report •
Drivers and restraints of the opioids market
•
Latest product innovations and key developments in the market
•
Analysis of business strategies of the top players
Persistence Market Research
3
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period
•
Opioids market estimates and forecasts
Market History: An opioid is a type of narcotic pain medication that is used to treat moderate to severe pain. It is used as an anesthesia, cough suppressant, diarrhea suppressant and to reduce surgical pain, injury or trauma, cancer pain and pain arising from disease. Opioids are largely used in cancer pain management and endstage diseases in which palliative care is required. However, these can be addictive due to their analgesic nature. The global opioids market was valued at US$ 33,924.2 Mn in 2014. North America was the leading market for opioid, accounting for approximately 65% revenue share in 2014, followed by Europe with around 20% share in 2014. Factors such as increasing palliative care facilities, reformed regulations for prescription of opioids, and extensive focus of generic manufacturers towards Abuse-Deterrent Formulation (ADF) are expected to drive the growth of the opioids market in North America and Europe. Asia Pacific market is expected to register highest CAGR of 3.5% during the forecast period (2015–2021), followed by the North America. Increased focus on palliative care and rising healthcare expenditure are leading factors which promote the growth of opioids in Asia Pacific. The global opioids market has been estimated to be valued at US$ 34,888.0 Mn in 2015 and is anticipate to garner US$ 42,158.8 Mn revenue by 2021, registering a CAGR of 3.2% during the forecast period. By product, the morphine and codeine segments collectively accounted for around 62% of the overall market in 2014. Uncontrolled prescription, development of opioid tolerance towards morphine and codeine would raise the demand through 2021. By application, analgesia segment was valued at US$ 22,776.3 Mn in 2014 and is anticipated to reach US$ 3,448.6 Mn by 2021 at a CAGR of 7.1% over the forecast period. Key players in the global opioids market include Pfizer Inc., Purdue Pharma, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Actavis Plc., Sanofi, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc. and Egalet.
Persistence Market Research
4
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period
Table of Content Table of Content 1. Research Methodology 2. Assumption & Acronyms Used 3. Executive Summary 4. Opioids Market Overview 4.1. Parent Market Overview 4.2. Market Taxonomy & Market Definition 4.3. Global Opioid Market Size and Forecast 4.3.1. Introduction 4.3.1.1. Global Opioid Market Value & Y-o-Y Growth Rate 2015-2021 4.3.1.2. Global Opioid Market Absolute $ Opportunity, 2015–2021 4.4. Market Dynamics 4.4.1. Drivers 4.4.2. Restraints 4.4.3. Trends 4.4.4. Opportunities 4.4.5. Market Dynamics Impact Analysis 5. Regulations & PEST Analysis 5.1. PEST Analysis 5.1.1. U.S. 5.1.2. Canada 5.1.3. Germany 5.2. Key Regulations 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa
Persistence Market Research
5
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period 6. Global Opioid Market Analysis and Forecast By Product Type 6.1. Introduction 6.1.1. BPS Analysis, By Product Type 6.1.2. Y-o-Y Growth Comparison, By Product Type 6.2. Morphine 6.2.1. Market Value & Y-o-Y Growth Rate 6.2.2. Market Absolute $ Opportunity 6.3. Codeine 6.3.1. Market Value & Y-o-Y Growth Rate 6.3.2. Market Absolute $ Opportunity 6.4. Fentanyl 6.4.1. Market Value & Y-o-Y Growth Rate 6.4.2. Market Absolute $ Opportunity 6.5. Meperidine 6.5.1. Market Value & Y-o-Y Growth Rate 6.5.2. Market Absolute $ Opportunity 6.6. Methadone 6.6.1. Market Value & Y-o-Y Growth Rate 6.6.2. Market Absolute $ Opportunity 6.7. Global Opioid Market Attractiveness Analysis By Product Type, 2015–2021 7. Global Opioid Market Analysis and Forecast By Application 7.1. Introduction 7.1.1. BPS Analysis, By Application 7.1.2. Y-o-Y Growth Comparison, By Application 7.2. Analgesia 7.2.1. Market Value & Y-o-Y Growth Rate 7.2.2. Market Absolute $ Opportunity 7.3. Cough Suppression 7.3.1. Market Value & Y-o-Y Growth Rate 7.3.2. Market Absolute $ Opportunity 7.4. Diarrhea Suppression 7.4.1. Market Value & Y-o-Y Growth Rate 7.4.2. Market Absolute $ Opportunity 7.5. Global Opioid Market Attractiveness Analysis By Application
Persistence Market Research
6
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period 8. Global Opioid Market Analysis and Forecast By Region 8.1. Introduction 8.1.1. BPS Analysis, By Region 8.1.2. Y-o-Y Growth Comparison, By Region 8.2. North America Opioid Market Analysis and Forecast 8.2.1. Market Value & Y-o-Y Growth Rate 8.2.2. Market Absolute $ Opportunity 8.3. Latin America Opioid Market Analysis and Forecast 8.3.1. Market Value & Y-o-Y Growth Rate 8.3.2. Market Absolute $ Opportunity 8.4. Europe Opioid Market Analysis and Forecast 8.4.1. Market Value & Y-o-Y Growth Rate 8.4.2. Market Absolute $ Opportunity 8.5. Asia Pacific Opioid Market Analysis and Forecast 8.5.1. Market Value & Y-o-Y Growth Rate 8.5.2. Market Absolute $ Opportunity 8.6. MEA Opioid Market Analysis and Forecast 8.6.1. Market Value & Y-o-Y Growth Rate 8.6.2. Market Absolute $ Opportunity 8.7. Global Opioid Market Attractiveness Analysis By Region 9. North America Opioid Market Analysis 9.1. North America Opioid Market: Trends 9.2. Market Value & Y-o-Y Growth Rate, By Country 9.3. North America Opioid Market: Country Analysis (Absolute $ Opportunity) 9.3.1. United States Opioid Market: Absolute $ Opportunity 9.3.2. Canada Opioid Market: Absolute $ Opportunity 9.4. North America Opioid Product Market 9.4.1. Morphine 9.4.1.1. Market Value & Y-o-Y Growth Rate 9.4.1.2. Market Absolute $ Opportunity 9.4.2. Codeine 9.4.2.1. Market Value & Y-o-Y Growth Rate 9.4.2.2. Market Absolute $ Opportunity 9.4.3. Fentanyl 9.4.3.1. Market Value & Y-o-Y Growth Rate
Persistence Market Research
7
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period 9.4.3.2. Market Absolute $ Opportunity 9.4.4. Meperidine 9.4.4.1. Market Value & Y-o-Y Growth Rate 9.4.4.2. Market Absolute $ Opportunity 9.4.5. Methadone 9.4.5.1. Market Value & Y-o-Y Growth Rate 9.4.5.2. Market Absolute $ Opportunity 9.5. North America Opioid Application Market 9.5.1. Analgesia 9.5.1.1. Market Value & Y-o-Y Growth Rate 9.5.1.2. Market Absolute $ Opportunity 9.5.2. Cough Suppression 9.5.2.1. Market Value & Y-o-Y Growth Rate 9.5.2.2. Market Absolute $ Opportunity 9.5.3. Diarrhea Suppression 9.5.3.1. Market Value & Y-o-Y Growth Rate 9.5.3.2. Market Absolute $ Opportunity 9.6. North America Opioid Market Attractiveness Analysis By Country 9.7. North America Opioid Market Attractiveness Analysis By Product Type 9.8. North America Opioid Market Attractiveness Analysis By Application 10. Latin America Opioid Market Analysis 10.1. Latin America Opioid Market: Trends 10.2. Market Value & Y-o-Y Growth Rate, By Country 10.3. Latin America Opioid Market: Country Analysis (Absolute $ Opportunity) 10.3.1. Brazil Opioid Market: Absolute $ Opportunity 10.3.2. Argentina Opioid Market: Absolute $ Opportunity 10.3.3. Mexico Opioid Market: Absolute $ Opportunity 10.3.4. Rest of Latin America Opioid Market: Absolute $ Opportunity 10.4. Latin America Opioid Product Market 10.4.1. Morphine 10.4.1.1. Market Value & Y-o-Y Growth Rate 10.4.1.2. Market Absolute $ Opportunity 10.4.2. Codeine 10.4.2.1. Market Value & Y-o-Y Growth Rate 10.4.2.2. Market Absolute $ Opportunity
Persistence Market Research
8
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period 10.4.3. Fentanyl 10.4.3.1. Market Value & Y-o-Y Growth Rate 10.4.3.2. Market Absolute $ Opportunity 10.4.4. Meperidine 10.4.4.1. Market Value & Y-o-Y Growth Rate 10.4.4.2. Market Absolute $ Opportunity 10.4.5. Methadone 10.4.5.1. Market Value & Y-o-Y Growth Rate 10.4.5.2. Market Absolute $ Opportunity 10.5. Latin America Opioid Application Market 10.5.1. Analgesia 10.5.1.1. Market Value & Y-o-Y Growth Rate 10.5.1.2. Market Absolute $ Opportunity 10.5.2. Cough Suppression 10.5.2.1. Market Value & Y-o-Y Growth Rate 10.5.2.2. Market Absolute $ Opportunity 10.5.3. Diarrhea Suppression 10.5.3.1. Market Value & Y-o-Y Growth Rate 10.5.3.2. Market Absolute $ Opportunity 10.6. Latin America Opioid Market Attractiveness Analysis By Country 10.7. Latin America Opioid Market Attractiveness Analysis By Product Type 10.8. Latin America Opioid Market Attractiveness Analysis By Application 11. Europe Opioid Market Analysis 11.1. Europe Opioid Market: Trends 11.2. Market Value & Y-o-Y Growth Rate, By Country 11.3. Europe Opioid Market: Country Analysis (Absolute $ Opportunity) 11.3.1. Germany Opioid Market: Absolute $ Opportunity 11.3.2. U.K. Opioid Market: Absolute $ Opportunity 11.3.3. Italy Opioid Market: Absolute $ Opportunity 11.3.4. France Opioid Market: Absolute $ Opportunity 11.3.5. Spain Opioid Market: Absolute $ Opportunity 11.3.6. Russia Opioid Market: Absolute $ Opportunity 11.3.7. Rest of Europe Opioid Market: Absolute $ Opportunity 11.4. Europe Opioid Product Market 11.4.1. Morphine
Persistence Market Research
9
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period 11.4.1.1. Market Value & Y-o-Y Growth Rate 11.4.1.2. Market Absolute $ Opportunity 11.4.2. Codeine 11.4.2.1. Market Value & Y-o-Y Growth Rate 11.4.2.2. Market Absolute $ Opportunity 11.4.3. Fentanyl 11.4.3.1. Market Value & Y-o-Y Growth Rate 11.4.3.2. Market Absolute $ Opportunity 11.4.4. Meperidine 11.4.4.1. Market Value & Y-o-Y Growth Rate 11.4.4.2. Market Absolute $ Opportunity 11.4.5. Methadone 11.4.5.1. Market Value & Y-o-Y Growth Rate 11.4.5.2. Market Absolute $ Opportunity 11.5. Europe Opioid Application Market 11.5.1. Analgesia 11.5.1.1. Market Value & Y-o-Y Growth Rate 11.5.1.2. Market Absolute $ Opportunity 11.5.2. Cough Suppression 11.5.2.1. Market Value & Y-o-Y Growth Rate 11.5.2.2. Market Absolute $ Opportunity 11.5.3. Diarrhea Suppression 11.5.3.1. Market Value & Y-o-Y Growth Rate 11.5.3.2. Market Absolute $ Opportunity 11.6. Europe Opioid Market Attractiveness Analysis By Country 11.7. Europe Opioid Market Attractiveness Analysis By Product Type 11.8. Europe Opioid Market Attractiveness Analysis By Application 12. Asia Pacific Opioid Market Analysis 12.1. Asia Pacific Opioid Market: Trends 12.2. Market Value & Y-o-Y Growth Rate, By Country 12.3. Asia Pacific Opioid Market: Country Analysis (Absolute $ Opportunity) 12.3.1. Greater China Opioid Market: Absolute $ Opportunity 12.3.2. India Opioid Market: Absolute $ Opportunity 12.3.3. ASEAN Opioid Market: Absolute $ Opportunity 12.3.4. Australia and New Zealand Opioid Market: Absolute $ Opportunity
Persistence Market Research
10
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period 12.3.5. Rest of APAC Opioid Market: Absolute $ Opportunity 12.4. Asia Pacific Opioid Product Market 12.4.1. Morphine 12.4.1.1. Market Value & Y-o-Y Growth Rate 12.4.1.2. Market Absolute $ Opportunity 12.4.2. Codeine 12.4.2.1. Market Value & Y-o-Y Growth Rate 12.4.2.2. Market Absolute $ Opportunity 12.4.3. Fentanyl 12.4.3.1. Market Value & Y-o-Y Growth Rate 12.4.3.2. Market Absolute $ Opportunity 12.4.4. Meperidine 12.4.4.1. Market Value & Y-o-Y Growth Rate 12.4.4.2. Market Absolute $ Opportunity 12.4.5. Methadone 12.4.5.1. Market Value & Y-o-Y Growth Rate 12.4.5.2. Market Absolute $ Opportunity 12.5. Asia Pacific Opioid Application Market 12.5.1. Analgesia 12.5.1.1. Market Value & Y-o-Y Growth Rate 12.5.1.2. Market Absolute $ Opportunity 12.5.2. Cough Suppression 12.5.2.1. Market Value & Y-o-Y Growth Rate 12.5.2.2. Market Absolute $ Opportunity 12.5.3. Diarrhea Suppression 12.5.3.1. Market Value & Y-o-Y Growth Rate 12.5.3.2. Market Absolute $ Opportunity 12.6. Asia Pacific Opioid Market Attractiveness Analysis By Country 12.7. Asia Pacific Opioid Market Attractiveness Analysis By Product Type 12.8. Asia Pacific Opioid Market Attractiveness Analysis By Application 13. MEA Opioid Market Analysis 13.1. MEA Opioid Market: Trends 13.2. Market Value & Y-o-Y Growth Rate, By Country 13.3. MEA Opioid Market: Country Analysis (Absolute $ Opportunity) 13.3.1. GCC Opioid Market: Absolute $ Opportunity
Persistence Market Research
11
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period 13.3.2. South Africa Opioid Market: Absolute $ Opportunity 13.3.3. Rest of MEA Opioid Market: Absolute $ Opportunity 13.4. MEA Opioid Product Market 13.4.1. Morphine 13.4.1.1. Market Value & Y-o-Y Growth Rate 13.4.1.2. Market Absolute $ Opportunity 13.4.2. Codeine 13.4.2.1. Market Value & Y-o-Y Growth Rate 13.4.2.2. Market Absolute $ Opportunity 13.4.3. Fentanyl 13.4.3.1. Market Value & Y-o-Y Growth Rate 13.4.3.2. Market Absolute $ Opportunity 13.4.4. Meperidine 13.4.4.1. Market Value & Y-o-Y Growth Rate 13.4.4.2. Market Absolute $ Opportunity 13.4.5. Methadone 13.4.5.1. Market Value & Y-o-Y Growth Rate 13.4.5.2. Market Absolute $ Opportunity 13.5. MEA Opioid Application Market 13.5.1. Analgesia 13.5.1.1. Market Value & Y-o-Y Growth Rate 13.5.1.2. Market Absolute $ Opportunity 13.5.2. Cough Suppression 13.5.2.1. Market Value & Y-o-Y Growth Rate 13.5.2.2. Market Absolute $ Opportunity 13.5.3. Diarrhea Suppression 13.5.3.1. Market Value & Y-o-Y Growth Rate 13.5.3.2. Market Absolute $ Opportunity 13.6. MEA Opioid Market Attractiveness Analysis By Country 13.7. MEA Opioid Market Attractiveness Analysis By Product Type 13.8. MEA Opioid Market Attractiveness Analysis By Application 14. Company Profiles 14.1. Company Dashboard 14.2. List of Suppliers and Distributors 14.3. Pfizer
Persistence Market Research
12
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period 14.4. Purdue Pharma 14.5. Boehringer Ingelheim 14.6. Janssen Pharmaceuticals, Inc. 14.7. Actavis Plc. 14.8. Sanofi 14.9. Sun Pharmaceutical Industries Ltd 14.10. Mallinckrodt Pharmaceuticals 14.11. Endo Pharmaceuticals Inc. 14.12. Egalet List of Table Table 01: Global Opioid Market, by Product, 2015–2021 (US$ Mn) Table 02: Global Opioid Market, by Application, 2014–2021 (US$ Mn) Table 03: North America Opioids Market, by Country, 2015–2021 (US$ Mn) Table 04: North America Opioids Market, by Product Type, 2015–2021 (US$ Mn) Table 05: North America Opioids Market, by Application, 2015–2021 (US$ Mn) Table 06: Latin America Opioids Market, by Country, 2015–2021 (US$ Mn) Table 07: Latin America Opioids Market, by Product Type, 2015–2021 (US$ Mn) Table 08: Latin America Opioids Market, by Application, 2015–2021 (US$ Mn) Table 09: Europe Opioids Market, by Country, 2015–2021 (US$ Mn) Table 10: Europe Opioids Market, by Product Type, 2015–2021 (US$ Mn) Table 11: Europe Opioids Market, by Application, 2015–2021 (US$ Mn) Table 12: Asia Pacific Opioids Market, by Country, 2015–2021 (US$ Mn) Table 13: Asia Pacific Opioids Market, by Product Type, 2015–2021 (US$ Mn) Table 14: Asia Pacific Opioids Market, by Application, 2015–2021 (US$ Mn) Table 15: MEA Opioids Market, by Country, 2015–2021 (US$ Mn) Table 16: MEA Opioids Market, by Product Type, 2015–2021 (US$ Mn) Table 17: MEA Opioids Market, by Application, 2015–2021 (US$ Mn) List of Figure Figure 01: Global Prescription Pain Management Drugs Market Snapshot (2014) Figure 02: Global Prescription Pain Management Drugs Market Value (US$ Bn) 2014–2021 Figure 03: Global Opioids Market Value & Y-o-Y Growth (%) Forecast, 2015–2021 Figure 04: Global Opioids Market Absolute $ Opportunity, 2015–2021
Persistence Market Research
13
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period Figure 05: Global Opioid Market Value Share & BPS Analysis, by Product Type, 2015 & 2021 Figure 06: Global Opioid Market Y-o-Y Growth Comparison, by Product Type, 2015–2021 Figure 07: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Morphine, 2015–2021 Figure 08: Global Opioid Market Absolute $ Opportunity, by Morphine, 2015–2021 Figure 09: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Codeine, 2015–2021 Figure 10: Global Opioid Market Absolute $ Opportunity, by Codeine, 2015–2021 Figure 11: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Fentanyl, 2015–2021 Figure 12: Global Opioid Market Absolute $ Opportunity, by Fentanyl, 2015–2021 Figure 13: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Meperidine, 2015– 2021 Figure 14: Global Opioid Market Absolute $ Opportunity, by Meperidine, 2015–2021 Figure 15: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Methadone, 2015– 2021 Figure 16: Global Opioid Market Absolute $ Opportunity, by Methadone, 2015–2021 Figure 17: Global Opioid Market Attractiveness Analysis, by Product Type, 2015–2021 Figure 18: Global Opioid Market Value Share & BPS Analysis, by application, 2015 & 2021 Figure 19: Global Opioid Market Y-o-Y Growth Comparison, by Application, 2015–2021 Figure 20: Global Opioid Product Type Market Value & Y-o-Y Growth (%) Forecast, by Analgesia, 2015–2021 Figure 21: Global Opioid Market Absolute $ Opportunity, by Analgesia, 2015–2021 Figure 22: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Cough Suppression, 2015–2021 Figure 23: Global Opioid Market Absolute $ Opportunity, by Cough Suppression, 2015–2021 Figure 24: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Diarrhea Suppression, 2015–2021 Figure 25: Global Opioid Market Absolute $ Opportunity, by Diarrhea Suppression, 2015– 2021 Figure 26: Global Opioid Market Attractiveness Analysis, by Application, 2015–2021 Figure 27: Opioid Market Y-o-Y Growth Comparison, by Region, 2015–2021 Figure 28: Global Opioid Market Attractiveness Analysis, by Region, 2015–2021 Figure 29: Global Opioid Market Value Share & BPS Analysis, by Region, 2015 & 2021 Figure 30: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by North America, 2015– 2021 Figure 31: Global Opioid Market Absolute $ Opportunity, by North America, 2015–2021
Persistence Market Research
14
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period Figure 32: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Latin America, 2015– 2021 Figure 33: Global Opioid Market Absolute $ Opportunity, by Latin America, 2015–2021 Figure 34: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Europe, 2015–2021 Figure 35: Global Opioid Market Absolute $ Opportunity, by Europe, 2015–2021 Figure 36: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Asia Pacific, 2015– 2021 Figure 37: Global Opioid Market Absolute $ Opportunity, by Asia Pacific, 2015–2021 Figure 38: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Middle East and Africa, 2015–2021 Figure 39: Global Opioid Market Absolute $ Opportunity, by Middle East and Africa, 2015– 2021 Figure 40: North America Opioids Market Y-o-Y Growth Comparison, by Country, 2015–2021 Figure 41: U.S. Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 42: Canada Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 43: North America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Morphine, 2015–2021 Figure 44: North America Opioids Market Absolute $ Opportunity, by Morphine, 2015–2021 Figure 45: North America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Codeine, 2015–2021 Figure 46: North America Opioids Market Absolute $ Opportunity, by Codeine, 2015–2021 Figure 47: North America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Fentanyl, 2015–2021 Figure 48: North America Opioids Market Absolute $ Opportunity, by Fentanyl, 2015–2021 Figure 49: North America Meperidine Opioids Market Value & Y-o-Y Growth (%), by Meperidine, 2015–2021 Figure 50: North America Meperidine Opioids Market Absolute $ Opportunity, by Meperidine, 2015–2021 Figure 51: North America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Methadone, 2015–2021 Figure 52: North America Opioids Market Absolute $ Opportunity, by Methadone, 2015–2021 Figure 53: North America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Analgesia, 2015–2021 Figure 54: North America Opioids Market Absolute $ Opportunity, by Analgesia, 2015–2021
Persistence Market Research
15
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period Figure 55: North America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Cough Suppression, 2015–2021 Figure 56: North America Cough Suppression Opioids Market Absolute $ Opportunity, by Cough Suppression, 2015–2021 Figure 57: North America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Diarrhea Suppression 2015–2021 Figure 58: North America Diarrhea Suppression Opioids Market Absolute $ Opportunity, by Diarrhea Suppression, 2015–2021 Figure 59: North America Opioids Market Attractiveness Analysis, by Country, 2015–2021 Figure 60: North America Opioids Market Attractiveness Analysis, by Product Type, 2015– 2021 Figure 61: North America Opioids Market Attractiveness Analysis, by Application, 2015–2021 Figure 62: Latin America Opioids Market Y-o-Y Growth Comparison, by Country, 2015–2021 Figure 63: Brazil Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 64: Argentina Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 65: Mexico Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 66: Rest of Latin America Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 67: Latin America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Morphine, 2015–2021 Figure 68: Latin America Opioids Market Absolute $ Opportunity, by Morphine, 2015–2021 Figure 69: Latin America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Codeine, 2015–2021 Figure 70: Latin America Opioids Market Absolute $ Opportunity, by Codeine, 2015–2021 Figure 71: Latin America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Fentanyl 2015–2021 Figure 72: Latin America Opioids Market Absolute $ Opportunity, by Fentanyl, 2015–2021 Figure 73: Latin America Opioids Market Value & Y-o-Y Growth (%), by Meperidine, 2015– 2021 Figure 74: Latin America Opioids Market Absolute $ Opportunity, by Meperidine, 2015–2021 Figure 75: Latin America Methadone Opioids Market Value & Y-o-Y Growth (%), by Methadone, 2015–2021 Figure 76: Latin America Methadone Opioids Market Absolute $ Opportunity, by Methadone, 2015–2021 Figure 77: Latin America Opioid Market Value & Y-o-Y Growth (%) Forecast, by Analgesia, 2015–2021
Persistence Market Research
16
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period Figure 78: Latin America Opioid Analgesics Market Absolute $ Opportunity, by Analgesia, 2015–2021 Figure 79: Latin America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Cough Suppression, 2015–2021 Figure 80: Latin America Opioids Market Absolute $ Opportunity, by Cough Suppression 2015–2021 Figure 81: Latin America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Diarrhea Suppression, 2015–2021 Figure 82: Latin America Opioids Market Absolute $ Opportunity, by Diarrhea Suppression, 2015–2021 Figure 83: Latin America Opioids Market Attractiveness Analysis, by Country, 2015–2021 Figure 84: Latin America Opioids Market Attractiveness Analysis, by Product Type, 2015–2021 Figure 85: Latin America Opioids Market Attractiveness Analysis, by Application, 2015–2021 Figure 86: Europe Opioids Market Y-o-Y Growth Comparison, by Country, 2015–2021 Figure 87: Germany Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 88: U.K. Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 89: Italy Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 90: France Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 91: Spain Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 92: Russia Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 93: Rest of Europe Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 94: Europe Opioids Market Value & Y-o-Y Growth (%) Forecast, by Morphine 2015–2021 Figure 95: Europe Opioids Market Absolute $ Opportunity, by Morphine, 2015–2021 Figure 96: Europe Opioids Market Value & Y-o-Y Growth (%) forecast, by Codeine, 2015–2021 Figure 97: Europe Opioids Market Absolute $ Opportunity, by Codeine, 2015–2021 Figure 98: Europe Opioids Market Value & Y-o-Y Growth (%) Forecast, by Fentanyl, 2015–2021 Figure 99: Europe Opioids Market Absolute $ Opportunity, by Fentanyl, 2015–2021 Figure 100: Europe Opioids Market Value & Y-o-Y Growth (%) Forecast, by Meperidine, 2015– 2021 Figure 101: Europe Opioids Market Absolute $ Opportunity, by Meperidine, 2015–2021 Figure 102: Europe Opioids Market Value & Y-o-Y Growth (%), forecast, by Methadone, 2015– 2021 Figure 103: Europe Opioids Market Absolute $ Opportunity, by Methadone, 2015–2021 Figure 104: Europe Opioid Market Value & Y-o-Y Growth (%) Forecast, by Analgesia, 2015– 2021
Persistence Market Research
17
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period Figure 105: Europe Opioid Market Absolute $ Opportunity, by Analgesia, 2015–2021 Figure 106: Europe Opioids Market Value & Y-o-Y Growth (%) Forecast, by Cough Suppression, 2015–2021 Figure 107: Europe Opioids Market Absolute $ Opportunity, by Cough Suppression, 2015– 2021 Figure 108: Europe Opioids Market Value & Y-o-Y Growth (%), Forecast, by Diarrhea Suppression, 2015–2021 Figure 109: Europe Opioids Market Absolute $ Opportunity, by Diarrhea Suppression, 2015– 2021 Figure 110: Europe Opioids Market Attractiveness Analysis, by Country, 2015–2021 Figure 111: Europe Opioids Market Attractiveness Analysis, by Product Type, 2015–2021 Figure 112: Europe Opioids Market Attractiveness Analysis, by Application, 2015–2021 Figure 113: Asia Pacific Opioids Market Y-o-Y Growth Comparison, by Country, 2015–2021 Figure 114: Greater China Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 115: India Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 116: ASEAN Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 117: ANZ Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 118: Rest of Asia Pacific Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 119: Asia Pacific Opioids Market Value & Y-o-Y Growth (%) Forecast, by Morphine, 2015–2021 Figure 120: Asia Pacific Morphine Opioids Market Absolute $ Opportunity, by Morphine, 2015–2021 Figure 121: Asia Pacific Opioids Market Value & Y-o-Y Growth (%) Forecast, by Codeine, 2015– 2021 Figure 122: Asia Pacific Opioids Market Absolute $ Opportunity, by Codeine, 2015–2021 Figure 123: Asia Pacific Opioids Market Value & Y-o-Y Growth (%) Forecast, by Fentanyl, 2015–2021 Figure 124: Asia Pacific Opioids Market Absolute $ Opportunity, by Fentanyl, 2015–2021 Figure 125: Asia Pacific Opioids Market Value & Y-o-Y Growth (%) Forecast, by Meperidine, 2015–2021 Figure 126: Asia Pacific Opioids Market Absolute $ Opportunity, by Meperidine, 2015–2021 Figure 127: Asia Pacific Opioids Market Value & Y-o-Y Growth (%) Forecast, by Methadone, 2015–2021 Figure 128: Asia Pacific Opioids Market Absolute $ Opportunity, by Methadone 2015–2021
Persistence Market Research
18
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period Figure 129: Asia Pacific Opioid Market Value & Y-o-Y Growth (%) Forecast, by Analgesia, 2015–2021 Figure 130: Asia Pacific Opioid Market Absolute $ Opportunity, by Analgesia, 2015–2021 Figure 131: Asia Pacific Opioids Market Value & Y-o-Y Growth (%) Forecast, by Cough Suppression, 2015–2021 Figure 132: Asia Pacific Opioids Market Absolute $ Opportunity, by Cough Suppression, 2015– 2021 Figure 133: Asia Pacific Opioids Market Value & Y-o-Y Growth (%) Forecast, by Diarrhea Suppression, 2015–2021 Figure 134: Asia Pacific Opioids Market Absolute $ Opportunity, by Diarrhea Suppression, 2015–2021 Figure 135: Asia Pacific Opioids Market Attractiveness Analysis, by Country, 2015–2021 Figure 136: Asia Pacific Opioids Market Attractiveness Analysis, by Product Type, 2015–2021 Figure 137: Asia Pacific Opioids Market Attractiveness Analysis, by Application, 2015–2021 Figure 138: MEA Opioids Market Y-o-Y Growth Comparison, by Country, 2015–2021 Figure 139: GCC Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 140: South Africa Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 142: Rest of MEA Opioids Market: Absolute $ Opportunity, 2014–2021 Figure 143: MEA Opioids Market Value & Y-o-Y Growth (%) Forecast, by Morphine, 2015–2021 Figure 144: MEA Opioids Market Absolute $ Opportunity, by Morphine, 2015–2021 Figure 145: MEA Opioids Market Value & Y-o-Y Growth (%) Forecast, by Codeine, 2015–2021 Figure 146: MEA Opioids Market Absolute $ Opportunity, by Codeine, 2015–2021 Figure 147: MEA Opioids Market Value & Y-o-Y Growth (%) Forecast, by Fentanyl, 2015–2021 Figure 148: MEA Opioids Market Absolute $ Opportunity, by Fentanyl, 2015–2021 Figure 149: MEA Opioids Market Value & Y-o-Y Growth (%) Forecast, by Meperidine, 2015– 2021 Figure 150: Opioids Market Absolute $ Opportunity, by Meperidine, 2015–2021 Figure 151: MEA Opioids Market Value & Y-o-Y Growth (%) Forecast, by Methadone, 2015– 2021 Figure 152: MEA Opioids Market Absolute $ Opportunity, by Methadone, 2015–2021 Figure 153: MEA Opioid Market Value & Y-o-Y Growth (%) Forecast, by Analgesia, 2015–2021 Figure 154: MEA Opioid Market Absolute $ Opportunity, by Analgesia, 2015–2021 Figure 155: MEA Cough Suppression Opioids Market Value & Y-o-Y Growth (%), 2015–2021 Figure 156: MEA Cough Suppression Opioids Market Absolute $ Opportunity, 2015–2021
Persistence Market Research
19
Opioids Market - Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period Figure 157: MEA Opioids Market Value & Y-o-Y Growth (%) Forecast, by Diarrhea Suppression, 2015–2021 Figure 158: MEA Opioids Market Absolute $ Opportunity, by Diarrhea Suppression, 2015– 2021 Figure 159: MEA Opioids Market Attractiveness Analysis, by Country, 2015–2021 Figure 160: MEA Opioids Market Attractiveness Analysis, by Product Type, 2015–2021 Figure 161: MEA Opioids Market Attractiveness Analysis, by Application, 2015–2021
About Us: Persistence Market Research is a global market research firm specializing- syndicated research, custom research, and consulting services
At Persistence Market Research (PMR), we are in the business of accelerating your business. As a fullservice market research firm, we stand committed to bringing more accuracy and speed to your business decisions. From ready-to-purchase market research reports to customized global research solutions, our engagement models are highly flexible without compromising on our deep-seated research values. Briefly stated, our mission is to give you access to forecasts and trends analyses that put you on the path to profitability.
PMR’s Services Go Beyond Gleaning Data
Most enterprises believe that IT and databases are enough to make an accurate decision. While we do not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar decision? We strive to deliver both even with demanding deadlines.
Contact Us: Addie Thomes 305 Broadway 7th Floor, New York City, NY 10007, United States, USA - Canada Toll Free: 800-961-0353 Email: sales@persistencemarketresearch.com Web: http://www.persistencemarketresearch.com
Persistence Market Research
20